Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
It may not be as well known as its fellow cannabinoids CBD and THC, but early research suggests CBG has significant potential in a range of health conditions; from easing anxiety to helping tackle antimicrobial resistance. Here’s everything you need to know.
CBG is one of around 144 cannabinoids found in the cannabis plant. Although it is not as well known as major cannabinoids CBD and THC, it has its own therapeutic effects and has demonstrated potential in early studies.
CBG is an abbreviation of cannabigerol, a non-psychoactive cannabinoid typically found in low-THC and high-CBD cannabis cultivars.
CBG is sometimes referred to as ‘the mother of all cannabinoids’ because it is a precursor molecule that is converted into other cannabinoids like CBD and THC during the plant's growth.
It is typically found in much smaller amounts in the plant, often less than 1%, while THC and CBD, two of the most abundant compounds found in the plant, can reach levels of 20% and above.
Like CBD, CBG is non-intoxicating, meaning that while it does interact with the endocannabinoid system, it won’t give you the ‘high’ often associated with cannabis and particularly, THC.
Products containing CBG are generally legal in the UK as long as they contain less than 0.2% THC. They can also be prescribed by a doctor as part of a patient’s medical cannabis treatment plan.
While both CBG and CBD offer some similarities, they differ in their chemical structure, abundance in the plant, interaction with receptors, and potential applications
CBG is believed to interact with both CB1 and CB2 receptors in the endocannabinoid system, potentially offering a broader range of potential effects. It has shown a particular affinity for the CB1 receptors, suggesting it may influence mood, pain perception, and other functions.
CBG may also influence the production or breakdown of endogenous cannabinoids, such as anandamide and 2-arachidonoylglycerol (2-AG), which play crucial roles in various physiological processes.
While research is ongoing, CBG has shown promise in studies for potential benefits including:
CBG is also thought to have anxiolytic effects, meaning it could help offset some of the unwanted side-effects of THC, such as anxiety and paranoia.
Although the clinical research in this area is limited so far, there have been a number of promising studies supporting the potential therapeutic effects and clinical application of CBG.
In a recent double-blind, placebo-controlled clinical trial — the first to examine the effects of CBG in humans— the cannabinoid demonstrated efficacy in reducing anxiety and stress, as well as enhancing verbal memory when compared to a placebo.
Research has also shown that CBG can reduce intraocular eye pressure caused by glaucoma, and it may be beneficial in treating conditions such as inflammatory bowel disease. For example, in one study, CBG increased the rate of tissue recovery in the colon and reduced inflammation. The authors also found that CBG was effective as a treatment to prevent colitis-associated damage.
Meanwhile, a study from 2020 suggested that CBG may help in the fight against antibiotic resistance. Researchers identified CBG as an antibacterial compound that may serve as a lead for new drug development. Their study found that it was not only antibacterial but it was effective in mice fighting a resilient form of bacteria referred to as methicillin-resistant Staphylococcus aureus (MRSA).
Yes, cannabis-based medicines containing CBG can be prescribed by your doctor at Releaf.
Although products with high levels of CBG are generally not as widely available, one of the medical cannabis cultivars grown here in the UK actually contains up to 2% CBG (17% THC, 2% CBG & <1% CBD), as well as a significant amount of CBGA.
However, it’s important to bear in mind that there is still a lot we don’t know about the long-term effects of CBG and how it interacts with other medications. Always speak to your specialist doctor before making any changes to your treatment plan.
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.
Am I eligible?Sarah, a distinguished journalist with over a decade in publishing and communications, now excels in cannabis health and policy journalism in the UK, advocating for informed health decisions through her award-winning work.
All of our articles are written by medical cannabis experts, guided by strict sourcing guidelines, and reference peer-reviewed studies and credible academic research. Our expert clinical team and compliance specialists provide valuable insights to ensure accuracy when required. Learn more in our editorial policy.
Need more help?
November is National COPD Awareness Month, a time dedicated to raising awareness of Chronic Obstructive Pulmonary Disease (COPD) and the prevention and treatment of chronic lung disease. In honour of this important event, we’re taking a closer look at the relationship between medical cannabis and chronic lung disease and answering the question: “Can I vape medical cannabis if I have COPD?”
Emily Ledger
Medical cannabis treatment is quite an individual process, which means there is no one-size-fits-all answer to the question of how often you should see your doctor. Each and every patient we see here at Releaf responds at least slightly differently to their treatment protocol. This is the main reason our world-class clinical team takes such a personalised approach to each patient's care and why it is essential that all patients see their doctor regularly.
Sam North
Disability History Month, taking place from 14 November— 20 December highlights the history of the equality and human rights struggles of disabled individuals in the UK.
Sarah Sinclair
